Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic fibrogenesis

B H Davis1, T F Kresina

  • 1Department of Medicine, University of Chicago, Illinois, USA.

Clinics in Laboratory Medicine
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

This study details hepatic fibrogenesis, a liver scarring process. It focuses on the hepatic stellate cell

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PEPFAR support of alcohol-HIV prevention activities in Namibia and Botswana: a framework for investigation, implementation and evaluation.

Global mental health (Cambridge, England)·2017
Same author

Fischer-Tropsch synthesis. Evaluation of an aluminum small channel reactor.

Faraday discussions·2017
Same author

Technical Report: Triple-Colour Staining Flow Cytometry for Co-Distribution of Thrombospondin Receptor (CD36), Ribonucleic Acid (RNA) and Fetal Haemoglobin (HbF) in Sickle Red Blood Cells.

Hematology (Amsterdam, Netherlands)·2016
Same author

The challenge of tetradic relationships in medically interpreted pediatric primary care visits: A descriptive study of communication practices.

Patient education and counseling·2016
Same author

Use of CD157 in FLAER-based assays for high-sensitivity PNH granulocyte and PNH monocyte detection.

Cytometry. Part B, Clinical cytometry·2013
Same author

Use of CD157 in FLAER-based assays for high-sensitivity PNH granulocyte and PNH monocyte detection.

Cytometry. Part B, Clinical cytometry·2013
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Area of Science:

  • Liver disease research
  • Cell biology
  • Molecular mechanisms of fibrosis

Background:

  • Hepatic fibrogenesis results from liver injury due to alcohol, infections, toxins, or autoimmune conditions.
  • Hepatic stellate cells (HSCs) are key players, proliferating and producing excess extracellular matrix during fibrosis.
  • Understanding HSCs is crucial for developing anti-fibrotic therapies.

Purpose of the Study:

  • To summarize matrix proteins involved in hepatic fibrogenesis.
  • To identify regulatory cytokines, kinases, and transcription factors in HSC activation.
  • To provide a comprehensive overview of fibrogenesis mechanisms.

Main Methods:

  • Literature review of studies on hepatic fibrogenesis.
  • Analysis of extracellular matrix protein synthesis in HSCs.

Related Experiment Videos

  • Identification of signaling pathways regulating HSCs.
  • Main Results:

    • Detailed catalog of matrix proteins implicated in liver fibrosis.
    • Identification of key cytokines (e.g., TGF-β) and signaling pathways (e.g., MAPK, JAK/STAT).
    • Summary of transcription factors (e.g., Smads, NF-κB) controlling HSC activation.

    Conclusions:

    • Hepatic stellate cell activation is central to liver fibrogenesis.
    • Multiple molecular players regulate HSCs, offering therapeutic targets.
    • Further research into these pathways can lead to novel treatments for liver fibrosis.